Syndax Pharmaceuticals, Inc. SNDX
Analyst Consensus
Price Objectif
Analyst historical
| Analyste | Entreprise | Prix lors de l'analyse | Prix cible | Gain potentiel | Date de publication |
|---|---|---|---|---|---|
| Peter Lawson | Barclays | 13.76 $ | 22 $ | 8.24 % | 04/11/2025 |
| David Dai | UBS | 9.795 $ | 35 $ | 25.21 % | 15/07/2025 |
| Corinne Johnson | Goldman Sachs | 9.82 $ | 18 $ | 8.18 % | 10/07/2025 |
| George Farmer | Scotiabank | 20.04 $ | 18 $ | -2.04 % | 13/11/2024 |
| David Dai | UBS | 18.54 $ | 37 $ | 18.46 % | 24/10/2024 |
| Yigal Nochomovitz | Citigroup | 20.09 $ | 34 $ | 13.91 % | 15/08/2024 |
| Jason Zemansky | Bank of America Securities | 19.58 $ | 31 $ | 11.42 % | 15/08/2024 |
| Peter Lawson | Barclays | 19.58 $ | 33 $ | 13.42 % | 15/08/2024 |
| Jason Zemansky | Bank of America Securities | 21.99 $ | 30 $ | 8.01 % | 30/07/2024 |
| Kelly Shi | Jefferies | 20.32 $ | 37 $ | 16.68 % | 28/06/2024 |
| Bradley Canino | Stifel Nicolaus | 22.38 $ | 40 $ | 17.62 % | 09/05/2024 |